Valazyd Co 80/12,5 80 mg/12,5 ; 160 mg/12,5 mg ; 160 mg/25 mg FC tablet
PDF Leaflet Revision Date: 03 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension.
Dosage (summary)
1 tablet daily; adjust based on clinical response.
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Lithium
- NSAIDs
- Potassium-sparing diuretics
Contraindications
- Hypersensitivity to components
- Severe renal impairment
- Pregnancy
- Bilateral renal artery stenosis
Common side effects
- Dizziness
- Hypotension
- Hypokalaemia
Counselling Points
- Monitor blood pressure regularly
- Report any signs of allergic reactions
- Avoid potassium supplements without consulting
Serious warnings
- Risk of angioedema
- Monitor potassium levels
- Dual blockade of RAAS contraindicated
Important Disclaimer
The Valazyd Co 80/12,5 80 mg/12,5 ; 160 mg/12,5 mg ; 160 mg/25 mg FC tablet professional information leaflet below is the property of Zydus Healthcare Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
